Changes in quantitative ultrasound imaging as the predictor of response to neoadjuvant chemotherapy in patients with breast cancer

被引：1

作者：

Piotrzkowska-Wroblewska, Hanna ^{[1
]}

Dobruch-Sobczak, Katarzyna ^{[2
]}

Gumowska, Magdalena ^{[2
]}

Litniewski, Jerzy ^{[1
]}

机构：

[1] Inst Fundamental Technol Res PAS, Dept Ultrasound, Warsaw, Poland

[2] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Radiol, Warsaw, Poland

来源：

2022 IEEE INTERNATIONAL ULTRASONICS SYMPOSIUM (IEEE IUS) | 2022年

关键词：

breast cancer; neoadjuvant chemotherapy; ultrasound; H-scan ultrasounds;

D O I：

10.1109/IUS54386.2022.9957940

中图分类号：

O42 [声学];

学科分类号：

070206 ; 082403 ;

摘要：

The presented study demonstrates the effectiveness of quantitative ultrasound imaging (H-scan ultrasound) in monitoring the breast cancer response to neoadjuvant chemotherapy and predicting pathological response. A group of 40 patients (51 breast tumors) participated in the study. The results showed that QUS imaging was able to distinguish between breast cancer patients responding and not responding to chemotherapy early in the course of treatment. Analysis of the percentage changes in red in the parametric images showed that this parameter can predict the response to treatment of patients with the area under the receiver operational characteristics (ROC) curve of 0.61, 0.70, 0.83, and 0.86, respectively, one week after 1st, 2nd, 3rd and 4th dose of treatment.

引用

页数：4

共 50 条

[41] Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapy
Lee, Kutei C.
Moffat, Bradford A.
Schott, Anne F.
Layman, Rachel
Ellingworth, Steven
Juliar, Rebecca
Khan, Amjad P.
Helvie, Mark
Meyer, Charles R.
Chenevert, Thomas L.
Rehemtulla, Alnawaz
Ross, Brian D.
CLINICAL CANCER RESEARCH, 2007, 13 (02) : 443 - 450
[42] Quantitative contrast-enhanced ultrasound evaluation of pathological complete response in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy
Wan, Cai-Feng
Liu, Xue-Song
Wang, Lin
Zhang, Jie
Lu, Jin-Song
Li, Feng-Hua
EUROPEAN JOURNAL OF RADIOLOGY, 2018, 103 : 118 - 123
[43] RADIONUCLIDE EVALUATION OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS
Solodyannikova, O.
RADIOTHERAPY AND ONCOLOGY, 2010, 94 : S30 - S30
[44] Response to neoadjuvant chemotherapy in patients with triple negative breast cancer
Abe, E.
Hayashi, N.
Yoshida, A.
Hamaoka, T.
Yagata, H.
Tsugawa, K.
Tsunoda-Shimizu, H.
Suzuki, K.
Nakamura, S.
CANCER RESEARCH, 2009, 69 (02) : 367S - 367S
[45] Radionuclide evaluation of response to neoadjuvant chemotherapy in breast cancer patients
Solodyannikova, O.
Voit, N.
Dzhuzha, D.
Sukach, G.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S305 - S305
[46] Prognostic factors for response to neoadjuvant chemotherapy in patients with breast cancer
Kang, S. Y.
Jung, Y. S.
Kim, K. S.
BREAST, 2011, 20 : S48 - S48
[47] The response to neoadjuvant chemotherapy as a prognostic factor in breast cancer patients
Ruiz, C
Barros, A
Motta, E
Pinotti, J
BREAST, 1997, 6 (05): : P949 - P949
[48] Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer
Hannemann, J
Oosterkamp, HM
Bosch, CAJ
Velds, A
Wessels, LFA
Loo, C
Rutgers, EJ
Rodenhuis, S
van de Vijver, MJ
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) : 3331 - 3342
[49] Diagnosis of complete response to neoadjuvant chemotherapy using diagnostic Imaging in primary breast cancer patients
Kanazawa, T
Akashi-Tanaka, S
Iwamoto, E
Takasugi, M
Shien, T
Kinoshita, T
Miyakawa, K
Shimizu, C
Ando, M
Katsumata, N
Fujiwara, Y
Fukutomi, T
BREAST JOURNAL, 2005, 11 (05): : 311 - 316
[50] Prediction of pathological complete response to neoadjuvant chemotherapy by magnetic resonance imaging in breast cancer patients
Michishita, Shintaro
Kim, Seung Jin
Shimazu, Kenzo
Sota, Yoshiaki
Naoi, Yasuto
Maruyama, Naomi
Kagara, Naofumi
Shimoda, Masafumi
Shimomura, Atsushi
Noguchi, Shinzaburo
BREAST, 2015, 24 (02): : 159 - 165

← 1 2 3 4 5 →